Location History:
- Blackrock, IE (2016 - 2017)
- Dublin, IE (2017 - 2021)
Company Filing History:
Years Active: 2016-2021
Title: **B Therese Kinsella: A Pioneer in Thromboxane Receptor Antagonism**
Introduction
B Therese Kinsella is an accomplished inventor based in Dublin, Ireland, recognized for her significant contributions to the field of pharmaceutical sciences. With a total of eight patents to her name, her innovative work focuses on developing novel chemical entities that target thromboxane receptors, which play a crucial role in various human diseases.
Latest Patents
Among her latest innovations, Kinsella's patents include novel thromboxane receptor antagonists. These inventions relate to chemical entities that act as antagonists to the thromboxane (TX) A receptor and the T prostanoid receptor (TP). Specifically, her research outlines the use of compounds that potentially treat diseases where thromboxane A and other incidental ligands of TP, such as endoperoxide prostaglandins, 20-hydroxyeicosatetraenoic acid, and free-radical derived isoprostanes, are involved. The compounds developed in her patents often incorporate a benzenesulfonyl urea structure, featuring a biphenylyloxy group and a nitrile group, showing promising results as selective TP antagonists.
Career Highlights
Kinsella has had a remarkable career, contributing to advancements in medicinal chemistry and pharmacology. She has worked with prestigious organizations such as University College Dublin, where she furthered her research and innovation in drug development. Kinsella's work not only showcases her individual talents but also contributes to the broader scientific community’s understanding of thromboxane receptors.
Collaborations
Throughout her career, Kinsella has collaborated with notable colleagues, including Helen Reid and Patrick Guiry. These partnerships have fostered a rich exchange of ideas and have enhanced the scope of her research, allowing her to push the boundaries of current scientific knowledge in her field.
Conclusion
B Therese Kinsella is a notable figure in pharmaceutical innovation, particularly in the area of thromboxane receptor antagonism. With her patented inventions and collaborative efforts, she continues to be an influential inventor, making strides that could lead to significant advancements in treating human diseases associated with thromboxane pathways. Her dedication to innovation underscores the importance of research and collaboration in the ongoing quest for medical advancements.